NourishAI, GenoRobotics and Infera Neuro Get Support from the EPFL Startup Launchpad

Three EPFL startup projects are advancing health and biotechnology with support from the Startup Launchpad. NourishAI, developing a precision nutrition platform for ALS patients, received an Ignition Grant of CHF 30,000. GenoRobotics, building a portable DNA sequencing device, and Infera Neuro, designing ultra-low-power brain chips to restore communication, each secured a CHF 100,000 Innogrant to advance their innovations.

NourishAI, a startup from Prof. Johan Auwerx’s lab, has secured a CHF 30,000 EPFL Startup Launchpad Ignition grant. The team is developing a precision-nutrition platform that uses multiomics and lifestyle data to predict individual nutrient needs. The grant will support a pilot study in ALS to validate its models, with plans to expand to other metabolic, neuromuscular, and aging-related conditions.

GenoRobotics, emerging from EPFL’s MAKE initiative and the LBNC lab, is creating a portable DNA-sequencing device that extracts and amplifies DNA directly in the field—cutting costs, delays, and the need for specialized labs. Thanks to an Innogrant, the team will finalize its prototype and run pilot projects in agriculture, customs, and biodiversity monitoring.

Infera Neuro, a spin-off from the Integrated Neurotechnologies Laboratory, is developing ultra-low-power neural chips that decode brain signals in real time, enabling faster, more natural communication for people who have lost the ability to speak. With the support of an Innogrant, the team will complete its prototype and prepare for larger clinical trials.

➡️ Source: EPFL | 📸 ©EPFL